Encompass Health Co. (NYSE:EHC) Shares Sold by Keeley Teton Advisors LLC

Keeley Teton Advisors LLC trimmed its holdings in Encompass Health Co. (NYSE:EHC) by 5.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,201 shares of the company’s stock after selling 1,361 shares during the quarter. Keeley Teton Advisors LLC’s holdings in Encompass Health were worth $2,143,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Charles Schwab Investment Management Inc. raised its holdings in shares of Encompass Health by 0.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 644,764 shares of the company’s stock valued at $59,544,000 after buying an additional 4,345 shares during the last quarter. Central Pacific Bank Trust Division increased its position in Encompass Health by 15.1% in the 4th quarter. Central Pacific Bank Trust Division now owns 3,195 shares of the company’s stock valued at $295,000 after acquiring an additional 418 shares during the period. Merit Financial Group LLC purchased a new stake in Encompass Health during the 4th quarter valued at approximately $374,000. MassMutual Private Wealth & Trust FSB lifted its position in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares during the period. Finally, US Bancorp DE grew its stake in shares of Encompass Health by 9.6% in the 4th quarter. US Bancorp DE now owns 1,380 shares of the company’s stock valued at $127,000 after purchasing an additional 121 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on EHC. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. StockNews.com downgraded shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Wednesday. Royal Bank of Canada reissued an “outperform” rating and set a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. KeyCorp lifted their price objective on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Monday, February 10th. Finally, Barclays increased their target price on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. One investment analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $107.67.

Encompass Health Stock Performance

Shares of EHC stock opened at $102.30 on Wednesday. Encompass Health Co. has a 1 year low of $78.53 and a 1 year high of $104.55. The stock has a market cap of $10.30 billion, a PE ratio of 22.94, a P/E/G ratio of 2.31 and a beta of 0.87. The stock has a fifty day moving average price of $99.66 and a 200 day moving average price of $98.11. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Sell-side analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date was Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is presently 15.25%.

Insiders Place Their Bets

In related news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.10% of the stock is currently owned by company insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.